- $1.05bn
- $10.93bn
- $741.67m
- 53
- 91
- 25
- 57
Annual balance sheet for Chimera Investment, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 110 | 269 | 386 | 265 | 222 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 563 | 81.2 | 69.5 | 61.8 | 77 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Other Assets | |||||
| Total Assets | 27,119 | 17,523 | 15,407 | 13,402 | 12,929 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 23,165 | 13,744 | 11,671 | 10,735 | 10,370 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,953 | 3,779 | 3,736 | 2,667 | 2,559 |
| Total Liabilities & Shareholders' Equity | 27,119 | 17,523 | 15,407 | 13,402 | 12,929 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |